Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content
(1992) In Cancer 70(1). p.114-119- Abstract
- BACKGROUND. Leiomyosarcoma of soft tissue is a rare tumor. There are different opinions regarding epidemiology and prognosis. METHODS. Epidemiology and prognosis were analyzed in a consecutive, population-based series of 48 patients with subcutaneous and deep-seated leiomyosarcoma in the extremities and trunk wall with a complete follow-up of a minimum of 3 years. Cutaneous tumors were not included. RESULTS. The annual incidence was 0.13/10(5). The ratio of men to women was 1.2, and the median age was 65 years. The thigh was the most common location. Almost half of the tumors were subcutaneous. The median tumor size was 6 cm (range, 1-25 cm). All patients were treated with surgery, and in 19 cases it was combined with adjuvant radiation... (More)
- BACKGROUND. Leiomyosarcoma of soft tissue is a rare tumor. There are different opinions regarding epidemiology and prognosis. METHODS. Epidemiology and prognosis were analyzed in a consecutive, population-based series of 48 patients with subcutaneous and deep-seated leiomyosarcoma in the extremities and trunk wall with a complete follow-up of a minimum of 3 years. Cutaneous tumors were not included. RESULTS. The annual incidence was 0.13/10(5). The ratio of men to women was 1.2, and the median age was 65 years. The thigh was the most common location. Almost half of the tumors were subcutaneous. The median tumor size was 6 cm (range, 1-25 cm). All patients were treated with surgery, and in 19 cases it was combined with adjuvant radiation therapy or chemotherapy. The cumulative 5-year survival rate was 64%. Multivariate analysis indicated that age of 60 years or greater (relative risk [RR] = 8) and intratumoral vascular invasion (RR = 4) were independent risk factors for death resulting from tumor. DNA aneuploidy (RR = 4) and tumor necrosis (RR = 3) were associated with poor prognosis, but did not reach statistic significance. CONCLUSIONS. Advanced age, vascular invasion, and DNA aneuploidy could be used to identify prognostic subgroups. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1106287
- author
- Gustafson, Pelle LU ; Willen, Helena ; Baldetorp, Bo LU ; Fernö, Mårten LU ; Åkerman, Måns LU and Rydholm, Anders LU
- organization
- publishing date
- 1992
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- soft tissue sarcoma, leiomyosarcoma, epidemiology, prognosis, population-based, multivariate analysis, DNA content
- in
- Cancer
- volume
- 70
- issue
- 1
- pages
- 114 - 119
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- pmid:1606532
- scopus:0026689887
- ISSN
- 1097-0142
- DOI
- 10.1002/1097-0142(19920701)70:1<114::AID-CNCR2820700119>3.0.CO;2-U
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Pathology, (Lund) (013030000), Oncology, MV (013035000), Department of Orthopaedics (Lund) (013028000)
- id
- 237b9c2c-0113-4124-b84e-95e19cf0a904 (old id 1106287)
- date added to LUP
- 2016-04-01 12:11:46
- date last changed
- 2021-09-26 05:01:45
@article{237b9c2c-0113-4124-b84e-95e19cf0a904, abstract = {{BACKGROUND. Leiomyosarcoma of soft tissue is a rare tumor. There are different opinions regarding epidemiology and prognosis. METHODS. Epidemiology and prognosis were analyzed in a consecutive, population-based series of 48 patients with subcutaneous and deep-seated leiomyosarcoma in the extremities and trunk wall with a complete follow-up of a minimum of 3 years. Cutaneous tumors were not included. RESULTS. The annual incidence was 0.13/10(5). The ratio of men to women was 1.2, and the median age was 65 years. The thigh was the most common location. Almost half of the tumors were subcutaneous. The median tumor size was 6 cm (range, 1-25 cm). All patients were treated with surgery, and in 19 cases it was combined with adjuvant radiation therapy or chemotherapy. The cumulative 5-year survival rate was 64%. Multivariate analysis indicated that age of 60 years or greater (relative risk [RR] = 8) and intratumoral vascular invasion (RR = 4) were independent risk factors for death resulting from tumor. DNA aneuploidy (RR = 4) and tumor necrosis (RR = 3) were associated with poor prognosis, but did not reach statistic significance. CONCLUSIONS. Advanced age, vascular invasion, and DNA aneuploidy could be used to identify prognostic subgroups.}}, author = {{Gustafson, Pelle and Willen, Helena and Baldetorp, Bo and Fernö, Mårten and Åkerman, Måns and Rydholm, Anders}}, issn = {{1097-0142}}, keywords = {{soft tissue sarcoma; leiomyosarcoma; epidemiology; prognosis; population-based; multivariate analysis; DNA content}}, language = {{eng}}, number = {{1}}, pages = {{114--119}}, publisher = {{John Wiley & Sons Inc.}}, series = {{Cancer}}, title = {{Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content}}, url = {{http://dx.doi.org/10.1002/1097-0142(19920701)70:1<114::AID-CNCR2820700119>3.0.CO;2-U}}, doi = {{10.1002/1097-0142(19920701)70:1<114::AID-CNCR2820700119>3.0.CO;2-U}}, volume = {{70}}, year = {{1992}}, }